Literature DB >> 26398341

Predictors of Microvascular Invasion in Hepatocellular Carcinoma.

Yo-Ichi Yamashita1, Ken Shirabe, Shinichi Aishima, Yoshihiko Maehara.   

Abstract

This chapter covers a range of important topics in the evaluation of the microvascular invasion (MVI) in hepatocellular carcinoma (HCC) before treatment. The malignant potential of HCC is reflected by the types of MVI such as portal venous (vp), hepatic vein (vv) or bile duct (b) infiltration. The identification of the type of MVI in HCC has a key role in decisions regarding the effective treatment of HCC. Here, we describe the possible and important predictors of MVI in HCC.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26398341     DOI： 10.1159/000438475

Source DB:  PubMed          Journal:  Dig Dis        ISSN： 0257-2753            Impact factor:   2.404


  5 in total

1.  Multimodal radiofrequency ablation versus laparoscopic hepatic resection for the treatment of primary hepatocellular carcinoma within Milan criteria in severely cirrhotic patients: long-term favorable outcomes over 10 years.

Authors:  Yo-Ichi Yamashita; Katsunori Imai; Takayoshi Kaida; Takanobu Yamao; Masayo Tsukamoto; Shigeki Nakagawa; Hirohisa Okabe; Akira Chikamoto; Takatoshi Ishiko; Tomoharu Yoshizumi; Tetsuo Ikeda; Yoshihiko Maehara; Hideo Baba
Journal:  Surg Endosc       Date:  2018-06-05       Impact factor: 4.584

2.  Perioperative Allogeneic Blood Transfusion Does not Influence Patient Survival After Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Authors:  Yo-Ichi Yamashita; Hiromitsu Hayashi; Katsunori Imai; Hirohisa Okabe; Shigeki Nakagawa; Fumimasa Kitamura; Norio Uemura; Yosuke Nakao; Toshihiko Yusa; Rumi Itoyama; Takanobu Yamao; Naoki Umesaki; Tatsunori Miyata; Akira Chikamoto; Mototsugu Shimokawa; Hideo Baba
Journal:  World J Surg       Date:  2019-11       Impact factor: 3.352

3.  The clinical application of PIVKA-II in hepatocellular carcinoma and chronic liver diseases: A multi-center study in China.

Authors:  Jun Ji; Lijuan Liu; Feifei Jiang; Xue Wen; Yu Zhang; Shengcong Li; Jinli Lou; Ying Wang; Ning Liu; Qiuyan Guo; Yongmei Jia; Chunfang Gao
Journal:  J Clin Lab Anal       Date:  2021-09-30       Impact factor: 2.352

4.  Microvascular invasion of single small hepatocellular carcinoma ≤3 cm: Predictors and optimal treatments.

Authors:  Yo-Ichi Yamashita; Katsunori Imai; Toshihiko Yusa; Yosuke Nakao; Yuki Kitano; Shigeki Nakagawa; Hirohisa Okabe; Akira Chikamoto; Takatoshi Ishiko; Tomoharu Yoshizumi; Shinichi Aishima; Yoshihiko Maehara; Hideo Baba
Journal:  Ann Gastroenterol Surg       Date:  2018-01-08

5.  Serum PON1 as a biomarker for the estimation of microvascular invasion in hepatocellular carcinoma.

Authors:  Guang-Yu Ding; Xiao-Dong Zhu; Yuan Ji; Guo-Ming Shi; Ying-Hao Shen; Jian Zhou; Jia Fan; Hui-Chuan Sun; Cheng Huang
Journal:  Ann Transl Med       Date:  2020-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.